NIH-funded research R01 grant

Investigating how a specific receptor affects brain injury after a stroke.

Official title: Endothelial complement C3a receptor mediated cerebral injury in a murine stroke model.

Funded at St. Joseph's Hospital and Medical Center · NIH-10943805 · Data updated 2026-11-12

This study is looking at how a specific receptor in the brain might affect inflammation and damage after a stroke, with the hope of finding new treatments that could help stroke patients recover better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Joseph's Hospital and Medical Center
NIH-funded
Lab location1 site (Phoenix, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$853,135
NIH project number1R01NS138528-01
Project IDNIH-10943805 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who have experienced a stroke and are undergoing treatment with tissue plasminogen activator (tPA).

Less likely to help

Patients who have not experienced a stroke or those with chronic neurological conditions unrelated to acute brain injury may not benefit from this research.

What this research studies

This research focuses on understanding the role of the complement C3a receptor in brain injury following a stroke. It aims to explore how this receptor contributes to inflammation and damage in the brain after ischemic events. By using a murine model, the study will assess the effects of inhibiting this receptor on brain function and recovery. The ultimate goal is to develop therapies that could improve outcomes for stroke patients by protecting the brain from secondary injuries.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance recovery and reduce disability in stroke patients.

How similar studies have gone: Previous research has shown promising results in targeting similar pathways for neuroprotection in stroke models, indicating potential for success in this approach.

Where this research is happening

  • St. Joseph's Hospital and Medical Center
    Phoenix, United States
    Active

Researchers

  • Principal investigator: Ducruet, Andrew Frederick — St. Joseph's Hospital and Medical Center
  • Study coordinator: Ducruet, Andrew Frederick

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.